Replimune Group, Inc. (REPL) Misses Q4 EPS by 235c

Replimune Group, Inc. (NASDAQ: REPL) reported Q4 EPS of ($3.07), $2.35 worse than the analyst estimate of ($0.72).

For earnings history and earnings-related data on Replimune Group, Inc. (REPL) click here.

You May Also Be Interested In

• EyePoint Pharmaceuticals (EYPT) call put ratio 1.4 calls to 1 put as share price up 8.9%
• BT Brands posts Q2 profit, cuts costs as restaurant sales dip
• Home Depot beats estimates, reaffirms fiscal 2026 guidance